Radiotherapy Market by Type (Product, Service), Technology (MRI LINAC, Stereotactic, Particle Therapy, Cobalt-60 Teletherapy), Procedure (IMRT, IGRT, 3D-CRT, LDR, HDR), Application (Prostate, Breast, Lung), End User (Hospital) & Region - Global Forecast to 2028
The global radiotherapy market is projected to reach USD 8.8 billion by 2028 from USD 6.9 billion in 2023, growing at a CAGR of 5.0% during the forecast period. The rising incidence of cancer worldwide, advancements in radiotherapy treatment technologies, and growing adoption of particle therapy among cancer centers globally are likely to support the growth of radiotherapy market during the forecast period.
“ Software & Services segment of global radiotherapy market to grow with the highest CAGR in the forecast period.”
Based on type, the radiotherapy market is segmented into products and software & services. The software & service segment is expected to register a higher growth rate majorly in well-established market such as North America and Europe. The ongoing advancements in radiotherapy and increasing demand for more precise, and personalized cancer care treatment plan are leading towards the development of innovative radiotherapy softwares & services.
“ External Beam Radiotherapy segment, by technology , accounted for the largest market share of global radiotherapy system market in 2022.”
Based on technology, the radiotherapy market has been segmented into external beam radiotherapy and internal beam radiotherapy. The external beam radiotherapy (EBRT) segment accounted for the largest share of radiotherapy in 2022, owing to widespread adoption external beam radiotherapy technology and continuous investment in R&D by market players for development and commercializing advanced external beam radiotherapy technologies.
“ Prostate cancer, by external beam radiotherapy application , accounted for the largest market share of in 2022.”
Based on application, the radiotherapy market is classified into two major segments—external beam radiotherapy and internal beam radiotherapy/brachytherapy applications.
The external beam radiotherapy applications segment is further segmeneted into breast, prostate cancer, head and neck cancer, lung cancer, colorectla cancer and other cancer
The internal beam radiotherapy/brachytherapy applications segment is further divided into prostate cancer, gynecological cancer, breast cancer, cervical cancer, penile cancer, and other cancers (lung cancer and head and neck cancers).
Prostate cancer accounted for the largest market share in 2022 owing to the increasing incidence of prostate cancer globally, advantages offered by external beam radiotherapy treatment for prostate cancer, and increase in research activities in the field of radiation therapy for prostate cancer treatment
North America accounted for the largest share of the radiotherapy market by region.
The global radiotherapy market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the largest regional market for radiotherapy products and services , whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. The largest share of North America can be attributed to the rapid adoption of advanced radiotherapy technologies, increases collaboration among radiotherapy software manufacturers and end users, presence of diverse network of healthcare facilities and services across countries of North America , and favorable reimbursement models supporting cancer care in the region
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage
This report studies the radiotherapy market based on product, technology, application, end-user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.
This report provides insights on the following pointers:
“ Software & Services segment of global radiotherapy market to grow with the highest CAGR in the forecast period.”
Based on type, the radiotherapy market is segmented into products and software & services. The software & service segment is expected to register a higher growth rate majorly in well-established market such as North America and Europe. The ongoing advancements in radiotherapy and increasing demand for more precise, and personalized cancer care treatment plan are leading towards the development of innovative radiotherapy softwares & services.
“ External Beam Radiotherapy segment, by technology , accounted for the largest market share of global radiotherapy system market in 2022.”
Based on technology, the radiotherapy market has been segmented into external beam radiotherapy and internal beam radiotherapy. The external beam radiotherapy (EBRT) segment accounted for the largest share of radiotherapy in 2022, owing to widespread adoption external beam radiotherapy technology and continuous investment in R&D by market players for development and commercializing advanced external beam radiotherapy technologies.
“ Prostate cancer, by external beam radiotherapy application , accounted for the largest market share of in 2022.”
Based on application, the radiotherapy market is classified into two major segments—external beam radiotherapy and internal beam radiotherapy/brachytherapy applications.
The external beam radiotherapy applications segment is further segmeneted into breast, prostate cancer, head and neck cancer, lung cancer, colorectla cancer and other cancer
The internal beam radiotherapy/brachytherapy applications segment is further divided into prostate cancer, gynecological cancer, breast cancer, cervical cancer, penile cancer, and other cancers (lung cancer and head and neck cancers).
Prostate cancer accounted for the largest market share in 2022 owing to the increasing incidence of prostate cancer globally, advantages offered by external beam radiotherapy treatment for prostate cancer, and increase in research activities in the field of radiation therapy for prostate cancer treatment
North America accounted for the largest share of the radiotherapy market by region.
The global radiotherapy market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the largest regional market for radiotherapy products and services , whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. The largest share of North America can be attributed to the rapid adoption of advanced radiotherapy technologies, increases collaboration among radiotherapy software manufacturers and end users, presence of diverse network of healthcare facilities and services across countries of North America , and favorable reimbursement models supporting cancer care in the region
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–48%, Tier 2–36%, and Tier 3– 16%
- By Designation: C-level–10%, Director-level–14%, and Others–76%
- By Region: North America–40%, Europe–32%, Asia Pacific–20%, Latin America–5%, MEA- 3%
Research Coverage
This report studies the radiotherapy market based on product, technology, application, end-user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.
This report provides insights on the following pointers:
- Analysis of key drivers (technological advancements, rising prevalence of cancer, growing use of particle therapy), restraints (lack of adequate healthcare, high cost of automated radiation therapy systems, dearth of skilled radiologist), opportunities (rising healthcare expenditure across developing countries), and challenges (risk of radiation exposure) influencing the growth of radiotherapy market
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the radiotherapy market
- Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the radiotherapy market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the radiotherapy market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 KEY STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.6 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key data from primary sources
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 3 GLOBAL RADIOTHERAPY MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION METHODOLOGY
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 USAGE-BASED MARKET ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: GLOBAL RADIOTHERAPY MARKET
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS
2.4.1 RESEARCH ASSUMPTIONS
2.4.2 RESEARCH LIMITATIONS
2.5 RECESSION IMPACT ANALYSIS
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
3 EXECUTIVE SUMMARY
FIGURE 7 RADIOTHERAPY MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 8 RADIOTHERAPY MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
FIGURE 9 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 10 RADIOTHERAPY MARKET SHARE, BY END USER, 2023 VS. 2028
FIGURE 11 RADIOTHERAPY MARKET: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS
4.1 RADIOTHERAPY MARKET OVERVIEW
FIGURE 12 RISING CANCER PREVALENCE WORLDWIDE TO DRIVE GROWTH
4.2 EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
4.3 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TECHNOLOGY AND REGION (2022)
FIGURE 13 LINACS HELD LARGEST SHARE IN 2O22
4.4 RADIOTHERAPY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 14 CHINA TO REGISTER HIGHEST CAGR OVER FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 15 RADIOTHERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Advancements in radiotherapy treatment technology
5.2.1.2 Growing patient population
FIGURE 16 PROJECTED INCREASE IN CANCER CASES, 2020–2040
5.2.1.3 Increasing initiatives to promote radiotherapy awareness
5.2.1.4 Growing use of particle therapy for cancer treatment
5.2.2 RESTRAINTS
5.2.2.1 Lack of adequate healthcare infrastructure
5.2.2.2 High capital cost of radiotherapy
5.2.2.3 Complexity of radiotherapy
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging economies
5.2.3.2 Favorable changes in US radiotherapy payment model
5.2.3.3 Government and private investments to meet rising demand for cancer treatment
5.2.4 CHALLENGES
5.2.4.1 Dearth of skilled personnel
5.2.4.2 Difficulties in visualizing tumors during radiotherapy
5.2.4.3 Risk of radiation exposure
5.3 PORTER’S FIVE FORCES ANALYSIS
TABLE 2 RADIOTHERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 DEGREE OF COMPETITION
5.4 REGULATORY LANDSCAPE
TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.4.1 NORTH AMERICA
5.4.1.1 US
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.2 CANADA
TABLE 7 CLASS II PRESCRIBED EQUIPMENT CERTIFICATES
5.4.3 EUROPE
5.4.4 ASIA PACIFIC
5.4.4.1 China
5.4.4.2 Japan
TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.4.5 INDIA
5.5 REIMBURSEMENT SCENARIO
TABLE 9 CPT CODES FOR MAJOR RADIOTHERAPY TREATMENT MODALITIES
TABLE 10 REIMBURSEMENT FOR RADIOTHERAPY PROCEDURES PER COURSE, 2021 VS 2022
TABLE 11 OPPS TECHNICAL PER PROCEDURE NATIONAL AVERAGE MEDICARE REIMBURSEMENT, 2021 VS 2022
TABLE 12 FREESTANDING PER COURSE NATIONAL AVERAGE MEDICARE REIMBURSEMENT, 2021 VS 2022
5.6 ECOSYSTEM/MARKET MAP
5.7 VALUE CHAIN ANALYSIS
5.7.1 RESEARCH & DEVELOPMENT
5.7.2 PROCUREMENT AND PRODUCT DEVELOPMENT
5.7.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES
FIGURE 17 VALUE CHAIN ANALYSIS
5.8 SUPPLY CHAIN ANALYSIS
5.8.1 PROMINENT COMPANIES
5.8.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.8.3 END USERS
FIGURE 18 SUPPLY CHAIN ANALYSIS
5.9 TRADE DATA
TABLE 13 IMPORT DATA FOR LINACS (HS CODE 902214), BY COUNTRY, 2017–2021 (USD MILLION)
TABLE 14 EXPORT DATA FOR LINACS (HS CODE 902214), BY COUNTRY, 2017–2021 (USD MILLION)
5.10 PRICING ANALYSIS
FIGURE 19 AVERAGE SELLING PRICES OF KEY PLAYERS FOR TOP TWO PRODUCTS
TABLE 15 AVERAGE SELLING PRICES OF KEY PLAYERS FOR TOP TWO PRODUCTS (USD)
TABLE 16 AVERAGE SELLING PRICE TRENDS
5.11 KEY CONFERENCES & EVENTS IN 2023–2025
TABLE 17 RADIOTHERAPY MARKET: DETAILED LIST OF MAJOR CONFERENCES & EVENTS
5.12 TECHNOLOGY ANALYSIS
5.13 PATENT ANALYSIS
FIGURE 20 TOP PATENT APPLICANTS FOR PROTON BEAM THERAPY, JANUARY 2012–OCTOBER 2023
FIGURE 21 TOP PATENT APPLICANTS FOR MEDICAL LINEAR ACCELERATORS, JANUARY 2012–OCTOBER 2023
5.14 CASE STUDY ANALYSIS
TABLE 18 CASE STUDY: ENHANCING PATIENT SAFETY—SBRT’S ROLE IN MINIMIZING RADIATION RISK IN AN ELDERLY PATIENT (90-YEAR-OLD FEMALE WITH A MEDICALLY INOPERABLE EARLY-STAGE NSCLC)
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
FIGURE 22 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX
5.16 KEY STAKEHOLDERS & BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY SYSTEMS
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY DEVICES
5.16.2 BUYING CRITERIA
FIGURE 24 KEY BUYING CRITERIA FOR RADIOTHERAPY
TABLE 20 KEY BUYING CRITERIA FOR RADIOTHERAPY
6 RADIOTHERAPY MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 21 RADIOTHERAPY MARKET, BY PRODUCT & SERVICE, 2022–2028 (USD MILLION)
6.2 PRODUCTS
6.2.1 CONTINUOUS DEVELOPMENT OF ADVANCED TECHNOLOGIES TO BOOST MARKET
TABLE 22 RADIOTHERAPY PRODUCTS MARKET, BY REGION, 2022–2028 (USD MILLION)
6.3 SOFTWARE & SERVICES
6.3.1 INCREASING DEMAND FOR PRECISE AND EFFECTIVE CANCER TREATMENT TO SUPPORT MARKET GROWTH
TABLE 23 RADIOTHERAPY SOFTWARE & SERVICES MARKET, BY REGION, 2022–2028 (USD MILLION)
7 RADIOTHERAPY MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
TABLE 24 RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
7.2 EXTERNAL BEAM RADIOTHERAPY
TABLE 25 EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 26 EXTERNAL BEAM RADIOTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3 LINACS
TABLE 27 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 28 LINACS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3.1 CONVENTIONAL LINACS
7.3.1.1 Long treatment duration to limit adoption
TABLE 29 CONVENTIONAL LINACS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3.2 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS
TABLE 30 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 31 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3.2.1 CyberKnife
7.3.2.1.1 Precise radiation delivery with robotic correction capabilities to drive market
TABLE 32 CYBERKNIFE MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3.2.2 Gamma Knife
7.3.2.2.1 Ongoing product development and launches to support growth
TABLE 33 GAMMA KNIFE MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3.2.3 TomoTherapy
7.3.2.3.1 High installation and maintenance costs to limit adoption
TABLE 34 TOMOTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3.3 MRI LINACS
7.3.3.1 Real-time imaging advantage to propel growth
TABLE 35 MRI LINACS MARKET, BY REGION, 2022–2028 (USD MILLION)
7.4 PARTICLE THERAPY
TABLE 36 PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2021–2028 (USD MILLION)
TABLE 37 PARTICLE THERAPY MARKET, BY REGION, 2021–2028 (USD MILLION)
7.4.1 CYCLOTRONS
7.4.1.1 Enhanced outcomes and other advantages to boost adoption
TABLE 38 CYCLOTRONS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.4.2 SYNCHROTRONS
7.4.2.1 Increasing investments in synchrotron facilities to drive market
TABLE 39 SYNCHROTRONS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.4.3 SYNCHROCYCLOTRONS
7.4.3.1 High space requirements limit widespread adoption
TABLE 40 SYNCHROCYCLOTRONS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.5 CONVENTIONAL COBALT-60 TELETHERAPY
7.5.1 COMPLEX DOSE DELIVERY PLANNING AND RADIATION EXPOSURE TO LIMIT MARKET ADOPTION
TABLE 41 CONVENTIONAL COBALT-60 TELETHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION)
7.6 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
TABLE 42 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 43 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION)
7.7 SEEDS
7.7.1 ADVERSE SIDE-EFFECTS ASSOCIATED WITH SEEDS TO LIMIT ADOPTION
TABLE 44 SEEDS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.8 AFTERLOADERS
7.8.1 PROPER POSITIONING AND BETTER CONTROL OF ISOTOPES IN MODERN AFTERLOADERS TO DRIVE DEMAND
TABLE 45 AFTERLOADERS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.9 IORT SYSTEMS
7.9.1 RISING ADOPTION OF ELECTRONIC BRACHYTHERAPY PROCEDURES TO SUPPORT GROWTH
TABLE 46 IORT SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.10 APPLICATORS
7.10.1 HIGH RISK OF RADIATION EXPOSURE IN MANUAL APPLICATORS TO LIMIT GROWTH
TABLE 47 APPLICATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.11 SYSTEMIC RADIOTHERAPY
7.11.1 HIGH RISK OF RADIATION EXPOSURE TO LIMIT ADOPTION
7.11.2 IOBENGUANE (I-131)
7.11.3 SAMARIUM-153
7.11.4 RHENIUM-186
7.11.5 OTHER SYSTEMIC RADIOTHERAPY PRODUCTS
8 RADIOTHERAPY MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 48 RADIOTHERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS
TABLE 49 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 50 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY REGION, 2022–2028 (USD MILLION)
8.2.1 PROSTATE CANCER
8.2.1.1 High incidence rate and efficiency of EBRT in prostate cancer treatment to support growth
TABLE 51 EXTERNAL BEAM RADIOTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2021–2028 (USD MILLION)
8.2.2 BREAST CANCER
8.2.2.1 Therapeutic benefits of EBRT to drive market
TABLE 52 EXTERNAL BEAM RADIOTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2021–2028 (USD MILLION)
8.2.3 LUNG CANCER
8.2.3.1 High prevalence of lung cancer and efficiency of EBRT to drive market
TABLE 53 EXTERNAL BEAM RADIOTHERAPY MARKET FOR LUNG CANCER, BY REGION, 2021–2028 (USD MILLION)
8.2.4 HEAD & NECK CANCER
8.2.4.1 Noninvasive treatment of head & neck cancers to drive market
TABLE 54 EXTERNAL BEAM RADIOTHERAPY MARKET FOR HEAD & NECK CANCER, BY REGION, 2021–2028 (USD MILLION)
8.2.5 COLORECTAL CANCER
8.2.5.1 High incidence of colorectal cancer to support market growth
TABLE 55 EXTERNAL BEAM RADIOTHERAPY MARKET FOR COLORECTAL CANCER, BY REGION, 2021–2028 (USD MILLION)
8.2.6 OTHER EXTERNAL BEAM RADIOTHERAPY APPLICATIONS
TABLE 56 OTHER EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY REGION, 2022–2028 (USD MILLION)
8.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS
TABLE 57 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 58 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
8.3.1 PROSTATE CANCER
8.3.1.1 Precision of brachytherapy to drive market
TABLE 59 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2022–2028 (USD MILLION)
8.3.2 GYNECOLOGICAL CANCER
8.3.2.1 Availability of alternatives to hinder adoption of brachytherapy
TABLE 60 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR GYNECOLOGICAL CANCER, BY REGION, 2021–2028 (USD MILLION)
8.3.3 BREAST CANCER
8.3.3.1 Wide usage as replacement for traditional EBRT to drive market
TABLE 61 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2021–2028 (USD MILLION)
8.3.4 CERVICAL CANCER
8.3.4.1 Effectiveness of combined brachytherapy-chemotherapy procedure to support adoption
TABLE 62 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR CERVICAL CANCER, BY REGION, 2021–2028 (USD MILLION)
8.3.5 PENILE CANCER
8.3.5.1 Rising awareness and effectiveness of brachytherapy to drive market
TABLE 63 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR PENILE CANCER, BY REGION, 2021–2028 (USD MILLION)
8.3.6 OTHER INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS
TABLE 64 OTHER INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
9 RADIOTHERAPY MARKET, BY PROCEDURE
9.1 INTRODUCTION
TABLE 65 RADIOTHERAPY MARKET, BY PROCEDURE, 2022–2028 (USD MILLION)
9.2 EXTERNAL BEAM RADIOTHERAPY
TABLE 66 EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 67 EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2.1 IMRT
9.2.1.1 Advantages over 2D and 3D-CRT to boost adoption
TABLE 68 IMRT MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2.2 IGRT
9.2.2.1 Growing demand in treating deep-seated tumors to drive market
TABLE 69 IGRT MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2.3 3D CONFORMAL RADIOTHERAPY
9.2.3.1 High precision and minimized damage to nearby tissues to boost adoption
TABLE 70 3D CONFORMAL RADIOTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2.4 SRT
9.2.4.1 Minimally invasive procedure to drive end-user preference
TABLE 71 SRT MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2.5 PARTICLE THERAPY
9.2.5.1 High usage as primary mode of cancer treatment to sustain market growth
TABLE 72 PARTICLE THERAPY MARKET, BY REGION, 2022–2028 (USD MILLION)
9.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
TABLE 73 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 74 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY REGION, 2021–2028 (USD MILLION)
9.3.1 LDR BRACHYTHERAPY
9.3.1.1 Low risk of radiation exposure to surrounding tissues to drive adoption
TABLE 75 LDR BRACHYTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION)
9.3.2 HDR BRACHYTHERAPY
9.3.2.1 Possibility of tissue injury to affect adoption
TABLE 76 HDR BRACHYTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION)
9.3.3 PDR BRACHYTHERAPY
9.3.3.1 Combination of advantages to boost growth
TABLE 77 PULSED-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION)
9.4 SYSTEMIC RADIOTHERAPY
9.4.1 HIGH COST OF RADIOPHARMACEUTICALS AND RISK OF RADIATION EXPOSURE TO LIMIT USAGE
9.4.2 INTRAVENOUS RADIOTHERAPY
9.4.3 ORAL RADIOTHERAPY
9.4.4 INSTILLATION RADIOTHERAPY
10 RADIOTHERAPY MARKET, BY END USER
10.1 INTRODUCTION
TABLE 78 RADIOTHERAPY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2 HOSPITALS
10.2.1 HOSPITALS TO DOMINATE END-USER MARKET
TABLE 79 RADIOTHERAPY MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION)
10.3 INDEPENDENT RADIOTHERAPY CENTERS
10.3.1 LOWER OPERATING COSTS AND CONVENIENCE TO SUPPORT MARKET GROWTH
TABLE 80 RADIOTHERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2021–2028 (USD MILLION)
11 RADIOTHERAPY MARKET, BY REGION
11.1 INTRODUCTION
TABLE 81 RADIOTHERAPY MARKET, BY REGION, 2022–2028 (USD MILLION)
11.2 NORTH AMERICA
11.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 25 NORTH AMERICA: RADIOTHERAPY MARKET SNAPSHOT
TABLE 82 NORTH AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
TABLE 83 NORTH AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 84 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 85 NORTH AMERICA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 86 NORTH AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 87 NORTH AMERICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2028 (USD MILLION)
TABLE 88 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
TABLE 89 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 90 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 91 NORTH AMERICA: RADIOTHERAPY MARKET, BY END USER, 2022–2028 (USD MILLION)
11.2.2 US
11.2.2.1 Changes in reimbursement scenario to drive market growth
TABLE 92 US: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 93 US: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 94 US: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 95 US: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.2.3 CANADA
11.2.3.1 Growing prevalence of cancer to drive demand for radiotherapy
TABLE 96 CANADA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 97 CANADA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 98 CANADA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 99 CANADA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.3 EUROPE
11.3.1 EUROPE: RECESSION IMPACT
TABLE 100 EUROPE: RADIOTHERAPY MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
TABLE 101 EUROPE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 102 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 103 EUROPE: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 104 EUROPE: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 105 EUROPE: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2028 (USD MILLION)
TABLE 106 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
TABLE 107 EUROPE: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 108 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 109 EUROPE: RADIOTHERAPY MARKET, BY END USER, 2022–2028 (USD MILLION)
11.3.2 GERMANY
11.3.2.1 Availability of novel radiotherapy products to drive market
TABLE 110 GERMANY: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 111 GERMANY: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 112 GERMANY: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 113 GERMANY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 High purchasing & maintenance costs of advanced radiotherapy systems to limit market growth
TABLE 114 FRANCE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 115 FRANCE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 116 FRANCE: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 117 FRANCE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.3.4 UK
11.3.4.1 High healthcare expenditure to drive market
TABLE 118 UK: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 119 UK: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 120 UK: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 121 UK: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.3.5 SPAIN
11.3.5.1 Growing research activities on cancer care drive market
TABLE 122 SPAIN: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 123 SPAIN: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 124 SPAIN: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 125 SPAIN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.3.6 ITALY
11.3.6.1 High number of oncology-specific clinical trials & studies to support market growth
TABLE 126 ITALY: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 127 ITALY: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 128 ITALY: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 129 ITALY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.3.7 REST OF EUROPE
TABLE 130 REST OF EUROPE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 131 REST OF EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 132 REST OF EUROPE: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 133 REST OF EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.4 ASIA PACIFIC
11.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 26 ASIA PACIFIC: RADIOTHERAPY MARKET SNAPSHOT
TABLE 134 ASIA PACIFIC: RADIOTHERAPY MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
TABLE 135 ASIA PACIFIC: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 136 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 137 ASIA PACIFIC: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 138 ASIA PACIFIC: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 139 ASIA PACIFIC: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2028 (USD MILLION)
TABLE 140 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
TABLE 141 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 142 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 143 ASIA PACIFIC: RADIOTHERAPY MARKET, BY END USER, 2022–2028 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 Rising geriatric population and cancer incidence to drive market
TABLE 144 JAPAN: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 145 JAPAN: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 146 JAPAN: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 147 JAPAN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.4.3 CHINA
11.4.3.1 Growing partnerships among market players to support growth
TABLE 148 CHINA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 149 CHINA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 150 CHINA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 151 CHINA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.4.4 INDIA
11.4.4.1 High need for radiotherapy systems to provide opportunities
TABLE 152 INDIA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 153 INDIA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 154 INDIA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 155 INDIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.4.5 SOUTH KOREA
11.4.5.1 Increasing incidence of cancer to support market
TABLE 156 SOUTH KOREA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 157 SOUTH KOREA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 158 SOUTH KOREA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 159 SOUTH KOREA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.4.6 AUSTRALIA
11.4.6.1 Availability of funding for cancer care & research to drive growth
TABLE 160 AUSTRALIA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 161 AUSTRALIA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 162 AUSTRALIA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 163 AUSTRALIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.4.7 REST OF ASIA PACIFIC
TABLE 164 REST OF ASIA PACIFIC: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 165 REST OF ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 166 REST OF ASIA PACIFIC: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 167 REST OF ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.5 LATIN AMERICA
11.5.1 LATIN AMERICA: RECESSION IMPACT
TABLE 168 LATIN AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
TABLE 169 LATIN AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 170 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 171 LATIN AMERICA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 172 LATIN AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 173 LATIN AMERICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2028 (USD MILLION)
TABLE 174 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2023–2028 (USD MILLION)
TABLE 175 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 176 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 177 LATIN AMERICA: RADIOTHERAPY MARKET, BY END USER, 2022–2028 (USD MILLION)
11.5.2 BRAZIL
11.5.2.1 Restricted affordability & access to radiotherapy to challenge market growth
TABLE 178 BRAZIL: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 179 BRAZIL: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 180 BRAZIL: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 181 BRAZIL: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.5.3 MEXICO
11.5.3.1 Rising target population to boost market growth
TABLE 182 MEXICO: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 183 MEXICO: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 184 MEXICO: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 185 MEXICO: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.5.4 REST OF LATIN AMERICA
TABLE 186 REST OF LATIN AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 187 REST OF LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 188 REST OF LATIN AMERICA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 189 REST OF LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
11.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET
11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 190 MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 191 MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 192 MIDDLE EAST & AFRICA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 193 MIDDLE EAST & AFRICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 194 MIDDLE EAST & AFRICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2028 (USD MILLION)
TABLE 195 MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
TABLE 196 MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 197 MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 198 MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY END USER, 2022–2028 (USD MILLION)
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 27 OVERVIEW OF STRATEGIES ADOPTED BY KEY RADIOTHERAPY PLAYERS (2020 TO 2023)
12.3 REVENUE ANALYSIS
FIGURE 28 REVENUE ANALYSIS OF TOP FIVE PLAYERS, 2019–2022
12.4 MARKET SHARE ANALYSIS
FIGURE 29 RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2022
12.5 COMPANY EVALUATION MATRIX
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
FIGURE 30 RADIOTHERAPY MARKET: COMPANY EVALUATION MATRIX, 2022
12.5.5 COMPANY FOOTPRINT
TABLE 199 PRODUCT FOOTPRINT (18 COMPANIES)
TABLE 200 REGIONAL FOOTPRINT (18 COMPANIES)
TABLE 201 COMPANY FOOTPRINT (18 COMPANIES)
12.6 START-UP/SME EVALUATION MATRIX
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
FIGURE 31 RADIOTHERAPY MARKET: START-UP/SME EVALUATION MATRIX, 2022
12.6.5 COMPETITIVE BENCHMARKING
TABLE 202 RADIOTHERAPY MARKET: DETAILED LIST OF KEY START-UPS/SMES
12.7 COMPETITIVE SCENARIO AND TRENDS
12.7.1 PRODUCT LAUNCHES & APPROVALS
12.7.2 DEALS
12.7.3 OTHER DEVELOPMENTS 211 "13 COMPANY PROFILES(Business overview, Products/Services/Solutions offered, Recent Developments, MNM view)*
13.1 KEY PLAYERS
13.1.1 SIEMENS HEALTHINEERS GMBH (VARIAN MEDICAL SYSTEMS, INC.)
TABLE 203 SIEMENS HEALTHINEERS GMBH: COMPANY OVERVIEW
FIGURE 32 SIEMENS HEALTHINEERS GMBH: COMPANY SNAPSHOT (2022)
13.1.2 ELEKTA
TABLE 204 ELEKTA: COMPANY OVERVIEW
FIGURE 33 ELEKTA: COMPANY SNAPSHOT (2022)
13.1.3 ACCURAY INCORPORATED
TABLE 205 ACCURAY INCORPORATED: COMPANY OVERVIEW
FIGURE 34 ACCURAY INCORPORATED: COMPANY SNAPSHOT (2023)
13.1.4 IBA WORLDWIDE (ION BEAM APPLICATIONS SA)
TABLE 206 IBA WORLDWIDE: COMPANY OVERVIEW
FIGURE 35 IBA WORLDWIDE: COMPANY SNAPSHOT (FY 2022)
13.1.5 VIEWRAY TECHNOLOGIES, INC.
TABLE 207 VIEWRAY TECHNOLOGIES, INC.: COMPANY OVERVIEW
FIGURE 36 VIEWRAY TECHNOLOGIES, INC.: COMPANY SNAPSHOT (FY 2022)
13.1.6 PERSPECTIVE THERAPEUTICS, INC.
TABLE 208 PERSPECTIVE THERAPEUTICS, INC.: COMPANY OVERVIEW
FIGURE 37 PERSPECTIVE THERAPEUTICS, INC.: COMPANY SNAPSHOT (FY 2022)
13.1.7 HITACHI LTD.
TABLE 209 HITACHI LTD.: COMPANY OVERVIEW
FIGURE 38 HITACHI LTD.: COMPANY SNAPSHOT (FY 2022)
13.1.8 SUMITOMO HEAVY INDUSTRIES LTD.
TABLE 210 SUMITOMO HEAVY INDUSTRIES LTD.: COMPANY OVERVIEW
FIGURE 39 SUMITOMO HEAVY INDUSTRIES: COMPANY SNAPSHOT (FY 2022)
13.1.9 CARL ZEISS MEDITEC AG
TABLE 211 CARL ZEISS MEDITEC AG: COMPANY OVERVIEW
FIGURE 40 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT (2021)
13.1.10 MIM SOFTWARE INC.
TABLE 212 MIM SOFTWARE INC.: COMPANY OVERVIEW
13.1.11 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
TABLE 213 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: COMPANY OVERVIEW
13.1.12 PROVISION HEALTHCARE
TABLE 214 PROVISION HEALTHCARE: COMPANY OVERVIEW
13.1.13 MEVION MEDICAL SYSTEMS
TABLE 215 MEVION MEDICAL SYSTEMS: COMPANY OVERVIEW
13.1.14 OPTIVUS PROTON THERAPY, INC.
TABLE 216 OPTIVUS PROTON THERAPY: COMPANY OVERVIEW
13.1.15 P-CURE
TABLE 217 P-CURE: COMPANY OVERVIEW
13.1.16 INTRAOP MEDICAL, INC.
TABLE 218 INTRAOP MEDICAL, INC.: COMPANY OVERVIEW
13.1.17 BEBIG MEDICAL
TABLE 219 BEBIG MEDICAL: COMPANY OVERVIEW
13.1.18 KONINKLIJKE PHILIPS N.V.
TABLE 220 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
FIGURE 41 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
13.1.19 RAYSEARCH LABORATORIES
TABLE 221 RAYSEARCH LABORATORIES: COMPANY OVERVIEW
FIGURE 42 RAYSEARCH LABORATORIES: COMPANY SNAPSHOT (2022)
13.1.20 THERAGENICS
TABLE 222 THERAGENICS CORPORATION: COMPANY OVERVIEW
13.2 OTHER PLAYERS
13.2.1 PROTOM INTERNATIONAL
13.2.2 DOSISOFT SA
13.2.3 ISOAID
13.2.4 MAGNETTX ONCOLOGY SOLUTIONS LTD.
13.2.5 BRAINLAB AG
*Details on Business overview, Products/Services/Solutions offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED
1.3.2 REGIONS COVERED
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 KEY STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.6 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key data from primary sources
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 3 GLOBAL RADIOTHERAPY MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION METHODOLOGY
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 USAGE-BASED MARKET ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: GLOBAL RADIOTHERAPY MARKET
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS
2.4.1 RESEARCH ASSUMPTIONS
2.4.2 RESEARCH LIMITATIONS
2.5 RECESSION IMPACT ANALYSIS
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
3 EXECUTIVE SUMMARY
FIGURE 7 RADIOTHERAPY MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 8 RADIOTHERAPY MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
FIGURE 9 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 10 RADIOTHERAPY MARKET SHARE, BY END USER, 2023 VS. 2028
FIGURE 11 RADIOTHERAPY MARKET: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS
4.1 RADIOTHERAPY MARKET OVERVIEW
FIGURE 12 RISING CANCER PREVALENCE WORLDWIDE TO DRIVE GROWTH
4.2 EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
4.3 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TECHNOLOGY AND REGION (2022)
FIGURE 13 LINACS HELD LARGEST SHARE IN 2O22
4.4 RADIOTHERAPY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 14 CHINA TO REGISTER HIGHEST CAGR OVER FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 15 RADIOTHERAPY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Advancements in radiotherapy treatment technology
5.2.1.2 Growing patient population
FIGURE 16 PROJECTED INCREASE IN CANCER CASES, 2020–2040
5.2.1.3 Increasing initiatives to promote radiotherapy awareness
5.2.1.4 Growing use of particle therapy for cancer treatment
5.2.2 RESTRAINTS
5.2.2.1 Lack of adequate healthcare infrastructure
5.2.2.2 High capital cost of radiotherapy
5.2.2.3 Complexity of radiotherapy
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging economies
5.2.3.2 Favorable changes in US radiotherapy payment model
5.2.3.3 Government and private investments to meet rising demand for cancer treatment
5.2.4 CHALLENGES
5.2.4.1 Dearth of skilled personnel
5.2.4.2 Difficulties in visualizing tumors during radiotherapy
5.2.4.3 Risk of radiation exposure
5.3 PORTER’S FIVE FORCES ANALYSIS
TABLE 2 RADIOTHERAPY MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 DEGREE OF COMPETITION
5.4 REGULATORY LANDSCAPE
TABLE 3 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 4 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.4.1 NORTH AMERICA
5.4.1.1 US
TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.2 CANADA
TABLE 7 CLASS II PRESCRIBED EQUIPMENT CERTIFICATES
5.4.3 EUROPE
5.4.4 ASIA PACIFIC
5.4.4.1 China
5.4.4.2 Japan
TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.4.5 INDIA
5.5 REIMBURSEMENT SCENARIO
TABLE 9 CPT CODES FOR MAJOR RADIOTHERAPY TREATMENT MODALITIES
TABLE 10 REIMBURSEMENT FOR RADIOTHERAPY PROCEDURES PER COURSE, 2021 VS 2022
TABLE 11 OPPS TECHNICAL PER PROCEDURE NATIONAL AVERAGE MEDICARE REIMBURSEMENT, 2021 VS 2022
TABLE 12 FREESTANDING PER COURSE NATIONAL AVERAGE MEDICARE REIMBURSEMENT, 2021 VS 2022
5.6 ECOSYSTEM/MARKET MAP
5.7 VALUE CHAIN ANALYSIS
5.7.1 RESEARCH & DEVELOPMENT
5.7.2 PROCUREMENT AND PRODUCT DEVELOPMENT
5.7.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES
FIGURE 17 VALUE CHAIN ANALYSIS
5.8 SUPPLY CHAIN ANALYSIS
5.8.1 PROMINENT COMPANIES
5.8.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.8.3 END USERS
FIGURE 18 SUPPLY CHAIN ANALYSIS
5.9 TRADE DATA
TABLE 13 IMPORT DATA FOR LINACS (HS CODE 902214), BY COUNTRY, 2017–2021 (USD MILLION)
TABLE 14 EXPORT DATA FOR LINACS (HS CODE 902214), BY COUNTRY, 2017–2021 (USD MILLION)
5.10 PRICING ANALYSIS
FIGURE 19 AVERAGE SELLING PRICES OF KEY PLAYERS FOR TOP TWO PRODUCTS
TABLE 15 AVERAGE SELLING PRICES OF KEY PLAYERS FOR TOP TWO PRODUCTS (USD)
TABLE 16 AVERAGE SELLING PRICE TRENDS
5.11 KEY CONFERENCES & EVENTS IN 2023–2025
TABLE 17 RADIOTHERAPY MARKET: DETAILED LIST OF MAJOR CONFERENCES & EVENTS
5.12 TECHNOLOGY ANALYSIS
5.13 PATENT ANALYSIS
FIGURE 20 TOP PATENT APPLICANTS FOR PROTON BEAM THERAPY, JANUARY 2012–OCTOBER 2023
FIGURE 21 TOP PATENT APPLICANTS FOR MEDICAL LINEAR ACCELERATORS, JANUARY 2012–OCTOBER 2023
5.14 CASE STUDY ANALYSIS
TABLE 18 CASE STUDY: ENHANCING PATIENT SAFETY—SBRT’S ROLE IN MINIMIZING RADIATION RISK IN AN ELDERLY PATIENT (90-YEAR-OLD FEMALE WITH A MEDICALLY INOPERABLE EARLY-STAGE NSCLC)
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
FIGURE 22 EMERGING TRENDS AND OPPORTUNITIES AFFECTING FUTURE REVENUE MIX
5.16 KEY STAKEHOLDERS & BUYING CRITERIA
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY SYSTEMS
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF RADIOTHERAPY DEVICES
5.16.2 BUYING CRITERIA
FIGURE 24 KEY BUYING CRITERIA FOR RADIOTHERAPY
TABLE 20 KEY BUYING CRITERIA FOR RADIOTHERAPY
6 RADIOTHERAPY MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 21 RADIOTHERAPY MARKET, BY PRODUCT & SERVICE, 2022–2028 (USD MILLION)
6.2 PRODUCTS
6.2.1 CONTINUOUS DEVELOPMENT OF ADVANCED TECHNOLOGIES TO BOOST MARKET
TABLE 22 RADIOTHERAPY PRODUCTS MARKET, BY REGION, 2022–2028 (USD MILLION)
6.3 SOFTWARE & SERVICES
6.3.1 INCREASING DEMAND FOR PRECISE AND EFFECTIVE CANCER TREATMENT TO SUPPORT MARKET GROWTH
TABLE 23 RADIOTHERAPY SOFTWARE & SERVICES MARKET, BY REGION, 2022–2028 (USD MILLION)
7 RADIOTHERAPY MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
TABLE 24 RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
7.2 EXTERNAL BEAM RADIOTHERAPY
TABLE 25 EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 26 EXTERNAL BEAM RADIOTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3 LINACS
TABLE 27 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 28 LINACS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3.1 CONVENTIONAL LINACS
7.3.1.1 Long treatment duration to limit adoption
TABLE 29 CONVENTIONAL LINACS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3.2 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS
TABLE 30 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 31 STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3.2.1 CyberKnife
7.3.2.1.1 Precise radiation delivery with robotic correction capabilities to drive market
TABLE 32 CYBERKNIFE MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3.2.2 Gamma Knife
7.3.2.2.1 Ongoing product development and launches to support growth
TABLE 33 GAMMA KNIFE MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3.2.3 TomoTherapy
7.3.2.3.1 High installation and maintenance costs to limit adoption
TABLE 34 TOMOTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3.3 MRI LINACS
7.3.3.1 Real-time imaging advantage to propel growth
TABLE 35 MRI LINACS MARKET, BY REGION, 2022–2028 (USD MILLION)
7.4 PARTICLE THERAPY
TABLE 36 PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2021–2028 (USD MILLION)
TABLE 37 PARTICLE THERAPY MARKET, BY REGION, 2021–2028 (USD MILLION)
7.4.1 CYCLOTRONS
7.4.1.1 Enhanced outcomes and other advantages to boost adoption
TABLE 38 CYCLOTRONS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.4.2 SYNCHROTRONS
7.4.2.1 Increasing investments in synchrotron facilities to drive market
TABLE 39 SYNCHROTRONS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.4.3 SYNCHROCYCLOTRONS
7.4.3.1 High space requirements limit widespread adoption
TABLE 40 SYNCHROCYCLOTRONS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.5 CONVENTIONAL COBALT-60 TELETHERAPY
7.5.1 COMPLEX DOSE DELIVERY PLANNING AND RADIATION EXPOSURE TO LIMIT MARKET ADOPTION
TABLE 41 CONVENTIONAL COBALT-60 TELETHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION)
7.6 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
TABLE 42 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 43 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION)
7.7 SEEDS
7.7.1 ADVERSE SIDE-EFFECTS ASSOCIATED WITH SEEDS TO LIMIT ADOPTION
TABLE 44 SEEDS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.8 AFTERLOADERS
7.8.1 PROPER POSITIONING AND BETTER CONTROL OF ISOTOPES IN MODERN AFTERLOADERS TO DRIVE DEMAND
TABLE 45 AFTERLOADERS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.9 IORT SYSTEMS
7.9.1 RISING ADOPTION OF ELECTRONIC BRACHYTHERAPY PROCEDURES TO SUPPORT GROWTH
TABLE 46 IORT SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.10 APPLICATORS
7.10.1 HIGH RISK OF RADIATION EXPOSURE IN MANUAL APPLICATORS TO LIMIT GROWTH
TABLE 47 APPLICATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
7.11 SYSTEMIC RADIOTHERAPY
7.11.1 HIGH RISK OF RADIATION EXPOSURE TO LIMIT ADOPTION
7.11.2 IOBENGUANE (I-131)
7.11.3 SAMARIUM-153
7.11.4 RHENIUM-186
7.11.5 OTHER SYSTEMIC RADIOTHERAPY PRODUCTS
8 RADIOTHERAPY MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 48 RADIOTHERAPY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS
TABLE 49 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 50 EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY REGION, 2022–2028 (USD MILLION)
8.2.1 PROSTATE CANCER
8.2.1.1 High incidence rate and efficiency of EBRT in prostate cancer treatment to support growth
TABLE 51 EXTERNAL BEAM RADIOTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2021–2028 (USD MILLION)
8.2.2 BREAST CANCER
8.2.2.1 Therapeutic benefits of EBRT to drive market
TABLE 52 EXTERNAL BEAM RADIOTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2021–2028 (USD MILLION)
8.2.3 LUNG CANCER
8.2.3.1 High prevalence of lung cancer and efficiency of EBRT to drive market
TABLE 53 EXTERNAL BEAM RADIOTHERAPY MARKET FOR LUNG CANCER, BY REGION, 2021–2028 (USD MILLION)
8.2.4 HEAD & NECK CANCER
8.2.4.1 Noninvasive treatment of head & neck cancers to drive market
TABLE 54 EXTERNAL BEAM RADIOTHERAPY MARKET FOR HEAD & NECK CANCER, BY REGION, 2021–2028 (USD MILLION)
8.2.5 COLORECTAL CANCER
8.2.5.1 High incidence of colorectal cancer to support market growth
TABLE 55 EXTERNAL BEAM RADIOTHERAPY MARKET FOR COLORECTAL CANCER, BY REGION, 2021–2028 (USD MILLION)
8.2.6 OTHER EXTERNAL BEAM RADIOTHERAPY APPLICATIONS
TABLE 56 OTHER EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY REGION, 2022–2028 (USD MILLION)
8.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS
TABLE 57 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 58 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
8.3.1 PROSTATE CANCER
8.3.1.1 Precision of brachytherapy to drive market
TABLE 59 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR PROSTATE CANCER, BY REGION, 2022–2028 (USD MILLION)
8.3.2 GYNECOLOGICAL CANCER
8.3.2.1 Availability of alternatives to hinder adoption of brachytherapy
TABLE 60 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR GYNECOLOGICAL CANCER, BY REGION, 2021–2028 (USD MILLION)
8.3.3 BREAST CANCER
8.3.3.1 Wide usage as replacement for traditional EBRT to drive market
TABLE 61 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR BREAST CANCER, BY REGION, 2021–2028 (USD MILLION)
8.3.4 CERVICAL CANCER
8.3.4.1 Effectiveness of combined brachytherapy-chemotherapy procedure to support adoption
TABLE 62 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR CERVICAL CANCER, BY REGION, 2021–2028 (USD MILLION)
8.3.5 PENILE CANCER
8.3.5.1 Rising awareness and effectiveness of brachytherapy to drive market
TABLE 63 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET FOR PENILE CANCER, BY REGION, 2021–2028 (USD MILLION)
8.3.6 OTHER INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS
TABLE 64 OTHER INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
9 RADIOTHERAPY MARKET, BY PROCEDURE
9.1 INTRODUCTION
TABLE 65 RADIOTHERAPY MARKET, BY PROCEDURE, 2022–2028 (USD MILLION)
9.2 EXTERNAL BEAM RADIOTHERAPY
TABLE 66 EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 67 EXTERNAL BEAM RADIOTHERAPY PROCEDURES MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2.1 IMRT
9.2.1.1 Advantages over 2D and 3D-CRT to boost adoption
TABLE 68 IMRT MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2.2 IGRT
9.2.2.1 Growing demand in treating deep-seated tumors to drive market
TABLE 69 IGRT MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2.3 3D CONFORMAL RADIOTHERAPY
9.2.3.1 High precision and minimized damage to nearby tissues to boost adoption
TABLE 70 3D CONFORMAL RADIOTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2.4 SRT
9.2.4.1 Minimally invasive procedure to drive end-user preference
TABLE 71 SRT MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2.5 PARTICLE THERAPY
9.2.5.1 High usage as primary mode of cancer treatment to sustain market growth
TABLE 72 PARTICLE THERAPY MARKET, BY REGION, 2022–2028 (USD MILLION)
9.3 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY
TABLE 73 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 74 INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY PROCEDURES MARKET, BY REGION, 2021–2028 (USD MILLION)
9.3.1 LDR BRACHYTHERAPY
9.3.1.1 Low risk of radiation exposure to surrounding tissues to drive adoption
TABLE 75 LDR BRACHYTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION)
9.3.2 HDR BRACHYTHERAPY
9.3.2.1 Possibility of tissue injury to affect adoption
TABLE 76 HDR BRACHYTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION)
9.3.3 PDR BRACHYTHERAPY
9.3.3.1 Combination of advantages to boost growth
TABLE 77 PULSED-DOSE-RATE BRACHYTHERAPY MARKET, BY REGION, 2021–2028 (USD MILLION)
9.4 SYSTEMIC RADIOTHERAPY
9.4.1 HIGH COST OF RADIOPHARMACEUTICALS AND RISK OF RADIATION EXPOSURE TO LIMIT USAGE
9.4.2 INTRAVENOUS RADIOTHERAPY
9.4.3 ORAL RADIOTHERAPY
9.4.4 INSTILLATION RADIOTHERAPY
10 RADIOTHERAPY MARKET, BY END USER
10.1 INTRODUCTION
TABLE 78 RADIOTHERAPY MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2 HOSPITALS
10.2.1 HOSPITALS TO DOMINATE END-USER MARKET
TABLE 79 RADIOTHERAPY MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION)
10.3 INDEPENDENT RADIOTHERAPY CENTERS
10.3.1 LOWER OPERATING COSTS AND CONVENIENCE TO SUPPORT MARKET GROWTH
TABLE 80 RADIOTHERAPY MARKET FOR INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2021–2028 (USD MILLION)
11 RADIOTHERAPY MARKET, BY REGION
11.1 INTRODUCTION
TABLE 81 RADIOTHERAPY MARKET, BY REGION, 2022–2028 (USD MILLION)
11.2 NORTH AMERICA
11.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE 25 NORTH AMERICA: RADIOTHERAPY MARKET SNAPSHOT
TABLE 82 NORTH AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
TABLE 83 NORTH AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 84 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 85 NORTH AMERICA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 86 NORTH AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 87 NORTH AMERICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2028 (USD MILLION)
TABLE 88 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
TABLE 89 NORTH AMERICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 90 NORTH AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 91 NORTH AMERICA: RADIOTHERAPY MARKET, BY END USER, 2022–2028 (USD MILLION)
11.2.2 US
11.2.2.1 Changes in reimbursement scenario to drive market growth
TABLE 92 US: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 93 US: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 94 US: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 95 US: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.2.3 CANADA
11.2.3.1 Growing prevalence of cancer to drive demand for radiotherapy
TABLE 96 CANADA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 97 CANADA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 98 CANADA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 99 CANADA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.3 EUROPE
11.3.1 EUROPE: RECESSION IMPACT
TABLE 100 EUROPE: RADIOTHERAPY MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
TABLE 101 EUROPE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 102 EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 103 EUROPE: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 104 EUROPE: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 105 EUROPE: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2028 (USD MILLION)
TABLE 106 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
TABLE 107 EUROPE: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 108 EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 109 EUROPE: RADIOTHERAPY MARKET, BY END USER, 2022–2028 (USD MILLION)
11.3.2 GERMANY
11.3.2.1 Availability of novel radiotherapy products to drive market
TABLE 110 GERMANY: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 111 GERMANY: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 112 GERMANY: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 113 GERMANY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.3.3 FRANCE
11.3.3.1 High purchasing & maintenance costs of advanced radiotherapy systems to limit market growth
TABLE 114 FRANCE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 115 FRANCE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 116 FRANCE: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 117 FRANCE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.3.4 UK
11.3.4.1 High healthcare expenditure to drive market
TABLE 118 UK: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 119 UK: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 120 UK: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 121 UK: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.3.5 SPAIN
11.3.5.1 Growing research activities on cancer care drive market
TABLE 122 SPAIN: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 123 SPAIN: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 124 SPAIN: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 125 SPAIN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.3.6 ITALY
11.3.6.1 High number of oncology-specific clinical trials & studies to support market growth
TABLE 126 ITALY: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 127 ITALY: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 128 ITALY: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 129 ITALY: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.3.7 REST OF EUROPE
TABLE 130 REST OF EUROPE: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 131 REST OF EUROPE: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 132 REST OF EUROPE: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 133 REST OF EUROPE: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.4 ASIA PACIFIC
11.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 26 ASIA PACIFIC: RADIOTHERAPY MARKET SNAPSHOT
TABLE 134 ASIA PACIFIC: RADIOTHERAPY MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
TABLE 135 ASIA PACIFIC: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 136 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 137 ASIA PACIFIC: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 138 ASIA PACIFIC: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 139 ASIA PACIFIC: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2028 (USD MILLION)
TABLE 140 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
TABLE 141 ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 142 ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 143 ASIA PACIFIC: RADIOTHERAPY MARKET, BY END USER, 2022–2028 (USD MILLION)
11.4.2 JAPAN
11.4.2.1 Rising geriatric population and cancer incidence to drive market
TABLE 144 JAPAN: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 145 JAPAN: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 146 JAPAN: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 147 JAPAN: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.4.3 CHINA
11.4.3.1 Growing partnerships among market players to support growth
TABLE 148 CHINA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 149 CHINA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 150 CHINA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 151 CHINA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.4.4 INDIA
11.4.4.1 High need for radiotherapy systems to provide opportunities
TABLE 152 INDIA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 153 INDIA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 154 INDIA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 155 INDIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.4.5 SOUTH KOREA
11.4.5.1 Increasing incidence of cancer to support market
TABLE 156 SOUTH KOREA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 157 SOUTH KOREA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 158 SOUTH KOREA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 159 SOUTH KOREA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.4.6 AUSTRALIA
11.4.6.1 Availability of funding for cancer care & research to drive growth
TABLE 160 AUSTRALIA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 161 AUSTRALIA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 162 AUSTRALIA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 163 AUSTRALIA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.4.7 REST OF ASIA PACIFIC
TABLE 164 REST OF ASIA PACIFIC: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 165 REST OF ASIA PACIFIC: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 166 REST OF ASIA PACIFIC: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 167 REST OF ASIA PACIFIC: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.5 LATIN AMERICA
11.5.1 LATIN AMERICA: RECESSION IMPACT
TABLE 168 LATIN AMERICA: RADIOTHERAPY MARKET, BY COUNTRY, 2022–2028 (USD MILLION)
TABLE 169 LATIN AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 170 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 171 LATIN AMERICA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 172 LATIN AMERICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 173 LATIN AMERICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2028 (USD MILLION)
TABLE 174 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2023–2028 (USD MILLION)
TABLE 175 LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 176 LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 177 LATIN AMERICA: RADIOTHERAPY MARKET, BY END USER, 2022–2028 (USD MILLION)
11.5.2 BRAZIL
11.5.2.1 Restricted affordability & access to radiotherapy to challenge market growth
TABLE 178 BRAZIL: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 179 BRAZIL: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 180 BRAZIL: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 181 BRAZIL: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.5.3 MEXICO
11.5.3.1 Rising target population to boost market growth
TABLE 182 MEXICO: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 183 MEXICO: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 184 MEXICO: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 185 MEXICO: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.5.4 REST OF LATIN AMERICA
TABLE 186 REST OF LATIN AMERICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 187 REST OF LATIN AMERICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 188 REST OF LATIN AMERICA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 189 REST OF LATIN AMERICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
11.6 MIDDLE EAST & AFRICA
11.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET
11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
TABLE 190 MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY TECHNOLOGY, 2022–2028 (USD MILLION)
TABLE 191 MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 192 MIDDLE EAST & AFRICA: LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 193 MIDDLE EAST & AFRICA: STEREOTACTIC ADVANCED ELECTRON/COBALT-60 LINACS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 194 MIDDLE EAST & AFRICA: PARTICLE THERAPY MARKET, BY SYSTEM TYPE, 2022–2028 (USD MILLION)
TABLE 195 MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY MARKET, BY PRODUCT TYPE, 2022–2028 (USD MILLION)
TABLE 196 MIDDLE EAST & AFRICA: EXTERNAL BEAM RADIOTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 197 MIDDLE EAST & AFRICA: INTERNAL BEAM RADIOTHERAPY/BRACHYTHERAPY APPLICATIONS MARKET, BY TYPE, 2022–2028 (USD MILLION)
TABLE 198 MIDDLE EAST & AFRICA: RADIOTHERAPY MARKET, BY END USER, 2022–2028 (USD MILLION)
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 27 OVERVIEW OF STRATEGIES ADOPTED BY KEY RADIOTHERAPY PLAYERS (2020 TO 2023)
12.3 REVENUE ANALYSIS
FIGURE 28 REVENUE ANALYSIS OF TOP FIVE PLAYERS, 2019–2022
12.4 MARKET SHARE ANALYSIS
FIGURE 29 RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2022
12.5 COMPANY EVALUATION MATRIX
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
FIGURE 30 RADIOTHERAPY MARKET: COMPANY EVALUATION MATRIX, 2022
12.5.5 COMPANY FOOTPRINT
TABLE 199 PRODUCT FOOTPRINT (18 COMPANIES)
TABLE 200 REGIONAL FOOTPRINT (18 COMPANIES)
TABLE 201 COMPANY FOOTPRINT (18 COMPANIES)
12.6 START-UP/SME EVALUATION MATRIX
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
FIGURE 31 RADIOTHERAPY MARKET: START-UP/SME EVALUATION MATRIX, 2022
12.6.5 COMPETITIVE BENCHMARKING
TABLE 202 RADIOTHERAPY MARKET: DETAILED LIST OF KEY START-UPS/SMES
12.7 COMPETITIVE SCENARIO AND TRENDS
12.7.1 PRODUCT LAUNCHES & APPROVALS
12.7.2 DEALS
12.7.3 OTHER DEVELOPMENTS 211 "13 COMPANY PROFILES(Business overview, Products/Services/Solutions offered, Recent Developments, MNM view)*
13.1 KEY PLAYERS
13.1.1 SIEMENS HEALTHINEERS GMBH (VARIAN MEDICAL SYSTEMS, INC.)
TABLE 203 SIEMENS HEALTHINEERS GMBH: COMPANY OVERVIEW
FIGURE 32 SIEMENS HEALTHINEERS GMBH: COMPANY SNAPSHOT (2022)
13.1.2 ELEKTA
TABLE 204 ELEKTA: COMPANY OVERVIEW
FIGURE 33 ELEKTA: COMPANY SNAPSHOT (2022)
13.1.3 ACCURAY INCORPORATED
TABLE 205 ACCURAY INCORPORATED: COMPANY OVERVIEW
FIGURE 34 ACCURAY INCORPORATED: COMPANY SNAPSHOT (2023)
13.1.4 IBA WORLDWIDE (ION BEAM APPLICATIONS SA)
TABLE 206 IBA WORLDWIDE: COMPANY OVERVIEW
FIGURE 35 IBA WORLDWIDE: COMPANY SNAPSHOT (FY 2022)
13.1.5 VIEWRAY TECHNOLOGIES, INC.
TABLE 207 VIEWRAY TECHNOLOGIES, INC.: COMPANY OVERVIEW
FIGURE 36 VIEWRAY TECHNOLOGIES, INC.: COMPANY SNAPSHOT (FY 2022)
13.1.6 PERSPECTIVE THERAPEUTICS, INC.
TABLE 208 PERSPECTIVE THERAPEUTICS, INC.: COMPANY OVERVIEW
FIGURE 37 PERSPECTIVE THERAPEUTICS, INC.: COMPANY SNAPSHOT (FY 2022)
13.1.7 HITACHI LTD.
TABLE 209 HITACHI LTD.: COMPANY OVERVIEW
FIGURE 38 HITACHI LTD.: COMPANY SNAPSHOT (FY 2022)
13.1.8 SUMITOMO HEAVY INDUSTRIES LTD.
TABLE 210 SUMITOMO HEAVY INDUSTRIES LTD.: COMPANY OVERVIEW
FIGURE 39 SUMITOMO HEAVY INDUSTRIES: COMPANY SNAPSHOT (FY 2022)
13.1.9 CARL ZEISS MEDITEC AG
TABLE 211 CARL ZEISS MEDITEC AG: COMPANY OVERVIEW
FIGURE 40 CARL ZEISS MEDITEC AG: COMPANY SNAPSHOT (2021)
13.1.10 MIM SOFTWARE INC.
TABLE 212 MIM SOFTWARE INC.: COMPANY OVERVIEW
13.1.11 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.
TABLE 213 PANACEA MEDICAL TECHNOLOGIES PVT. LTD.: COMPANY OVERVIEW
13.1.12 PROVISION HEALTHCARE
TABLE 214 PROVISION HEALTHCARE: COMPANY OVERVIEW
13.1.13 MEVION MEDICAL SYSTEMS
TABLE 215 MEVION MEDICAL SYSTEMS: COMPANY OVERVIEW
13.1.14 OPTIVUS PROTON THERAPY, INC.
TABLE 216 OPTIVUS PROTON THERAPY: COMPANY OVERVIEW
13.1.15 P-CURE
TABLE 217 P-CURE: COMPANY OVERVIEW
13.1.16 INTRAOP MEDICAL, INC.
TABLE 218 INTRAOP MEDICAL, INC.: COMPANY OVERVIEW
13.1.17 BEBIG MEDICAL
TABLE 219 BEBIG MEDICAL: COMPANY OVERVIEW
13.1.18 KONINKLIJKE PHILIPS N.V.
TABLE 220 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
FIGURE 41 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
13.1.19 RAYSEARCH LABORATORIES
TABLE 221 RAYSEARCH LABORATORIES: COMPANY OVERVIEW
FIGURE 42 RAYSEARCH LABORATORIES: COMPANY SNAPSHOT (2022)
13.1.20 THERAGENICS
TABLE 222 THERAGENICS CORPORATION: COMPANY OVERVIEW
13.2 OTHER PLAYERS
13.2.1 PROTOM INTERNATIONAL
13.2.2 DOSISOFT SA
13.2.3 ISOAID
13.2.4 MAGNETTX ONCOLOGY SOLUTIONS LTD.
13.2.5 BRAINLAB AG
*Details on Business overview, Products/Services/Solutions offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
